Sao Tome and Principe vs Venezuela: The number of people with susceptibility test result for rifampicin
Sao Tome and Principe
0
in 2021
Venezuela
3.31
in 2021
Sao Tome and Principe rank
142nd
Venezuela rank
140th
The number of people with susceptibility test result for rifampicin over time
- Sao Tome and Principe
- Venezuela
How they compare
Venezuela currently reports 3.31 against 0 in Sao Tome and Principe, a difference of 3.31.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Sao Tome and Principe ahead.
Sao Tome and Principe ranks 142nd and Venezuela ranks 140th of 146 countries.
Across the 2 decades both report, Sao Tome and Principe averaged higher in 1 and Venezuela in 1.
Head to head by decade
| Decade | Sao Tome and Principe | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.76 | 5.64 | 15.12 | Sao Tome and Principe |
| 2020s | 1.04 | 2.56 | 1.52 | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Sao Tome and Principe or Venezuela?
- Venezuela, at 3.31 against 0 in Sao Tome and Principe as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Sao Tome and Principe and Venezuela?
- 3.31, with Venezuela ahead.
- How many years of comparable data are there for Sao Tome and Principe and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do Sao Tome and Principe and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- Sao Tome and Principe ranks 142nd and Venezuela ranks 140th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.